Blue light‐mediated gene expression as a promising strategy to reduce antibiotic resistance in Escherichia coli
Biotechnology Journal · 2024
DOI: 10.1002/biot.202400023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Qingwei Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Food Science and Technology, Nanjing Agricultural University, Nanjing, PR China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Blue Light, Escherichia coli. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
The discovery of antibiotics has noticeably promoted the development of human civilization; however, antibiotic resistance in bacteria caused by abusing and overusing greatly challenges human health and food safety. Considering the worsening situation, it is an urgent demand to develop emerging nontraditional technologies or methods to address this issue. With the expanding of synthetic biology, optogenetics exhibits a tempting prospect for precisely regulating gene expression in many fields. Consequently, it is attractive to employ optogenetics to reduce the risk of antibiotic resistance. Here, a blue light‐controllable gene expression system was established in Escherichia coli based on a photosensitive DNA‐binding protein (EL222). Further, this strategy was successfully applied to repress the expression of β‐lactamase gene ( bla ) using blue light illumination, resulting a dramatic reduction of ampicillin resistance in engineered E. coli . Moreover, blue light was utilized to induce the expression of the mechanosensitive channel of large conductance (MscL), triumphantly leading to the increase of streptomycin susceptibility in engineered E. coli . Finally, the increased susceptibility of ampicillin and streptomycin was simultaneously induced by blue light in the same E. coli cell, revealing the excellent potential of this strategy in controlling multidrug‐resistant (MDR) bacteria. As a proof of concept, our work demonstrates that light can be used as an alternative tool to prolong the use period of common antibiotics without developing new antibiotics. And this novel strategy based on optogenetics shows a promising foreground to combat antibiotic resistance in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Food Science and Technology, Nanjing Agricultural University, Nanjing, PR China.
- College of Pharmacy, Binzhou Medical University, Yantai, PR China.
ORCID-Profile: Fengxia Lu, Libang Zhou
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Jiang, Q., Geng, F., Shen, J., Zhu, P., Lu, Z., Lu, F., & Zhou, L. (2024). Blue light‐mediated gene expression as a promising strategy to reduce antibiotic resistance in Escherichia coli. Biotechnology Journal. https://doi.org/10.1002/biot.202400023
Vancouver
Jiang Q, Geng F, Shen J, Zhu P, Lu Z, Lu F, et al. Blue light‐mediated gene expression as a promising strategy to reduce antibiotic resistance in Escherichia coli. Biotechnology Journal. 2024. doi:10.1002/biot.202400023
BibTeX
@article{Jiang2024,
author = {Jiang, Qingwei and Geng, Feng and Shen, Juan and Zhu, Ping and Lu, Zhaoxin and Lu, Fengxia and Zhou, Libang},
title = {Blue light‐mediated gene expression as a promising strategy to reduce antibiotic resistance in Escherichia coli},
journal = {Biotechnology Journal},
year = {2024},
doi = {10.1002/biot.202400023}
}
EUVIMED